Matthew K. Tollefson, M.D.

  1. Urologist
  1. Norasi H, Kim J, Hallbeck MS, Cerri PE, Elli EF, Tollefson MK, Harold KL, Pathak RA, Pak R. Surgeons' dominant surgical modality: Impacts on wellbeing, burnout, and interventions for neuromusculoskeletal disorders. Am J Surg. 2024 Nov; 237:115769 Epub 2024 May 18
    View PubMed
  2. Sharma V, Fadel A, Tollefson MK, Psutka SP, Blezek DJ, Frank I, Thapa P, Tarrell R, Viers LD, Potretzke AM, Hartman RP, Boorjian SA, Viers BR. Artificial Intelligence-Based Assessment of Preoperative Body Composition is Associated With Early Complications After Radical Cystectomy. J Urol. 2024 Oct 11; 101097JU0000000000004292 [Epub ahead of print]
    View PubMed
  3. Deol ES, Sharma V, Fadel AE, Vasdev R, Henning G, Basourakos S, Ghaffar U, Tollefson MK, Frank I, Houston Thompson R, Karnes RJ, Boorjian SA, Khanna A. Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose? Urology. 2024 Aug 28 [Epub ahead of print]
    View PubMed
  4. Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Buyyounouski MK, Chan K, Chang SS, Chang P, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kishan AU, Kundu S, Lele SM, Mamtani R, Mian OY, Michalski J, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Stewart T, Sundi D, Tollefson M, Tward J, Wright JL, Cassara CJ, Gurski LA. Bladder Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 May; 22 (4):216-225
    View PubMed
  5. Campbell RA, Khanna A, Boorjian SA, Knorr J, Cox R, Nicholas M, Cheville J, Sharma V, Murthy PB, Tarrell R, Thapa P, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Haber GP, Lee B. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy. Clin Genitourin Cancer. 2024 Apr; 22 (2):157-163.e1 Epub 2023 Oct 26
    View PubMed
  6. Khanna A, Antolin A, Bar O, Ben-Ayoun D, Zohar M, Boorjian SA, Frank I, Shah P, Sharma V, Thompson RH, Wolf T, Asselmann D, Tollefson M. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence. J Urol. 2024 Apr; 211 (4):575-584 Epub 2024 Jan 24
    View PubMed
  7. Mian AH, Tollefson MK, Shah P, Sharma V, Mian A, Thompson RH, Boorjian SA, Frank I, Khanna A. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy. J Clin Med. 2024 Jan 9; 13 (2) Epub 2024 Jan 09
    View PubMed
  8. Deol ES, Tollefson MK, Antolin A, Zohar M, Bar O, Ben-Ayoun D, Mynderse LA, Lomas DJ, Avant RA, Miller AR, Elliott DS, Boorjian SA, Wolf T, Asselmann D, Khanna A. Automated surgical step recognition in transurethral bladder tumor resection using artificial intelligence: transfer learning across surgical modalities. Front Artif Intell. 2024; 7:1375482 Epub 2024 Mar 07
    View PubMed
  9. Tollefson MK, Ross CJ. Defining the Standard for Surgical Video Deidentification. JAMA Surg. 2024 Jan 1; 159 (1):104-105
    View PubMed
  10. Norasi H, Hallbeck MS, Elli EF, Tollefson MK, Harold KL, Pak R. Impact of preferred surgical modality on surgeon wellness: a survey of workload, physical pain/discomfort, and neuromusculoskeletal disorders. Surg Endosc. 2023 Dec; 37 (12):9244-9254 Epub 2023 Oct 23
    View PubMed
  11. Nabavizadeh R, Rodrigues Pessoa R, Dumbrava MG, Packiam VT, Thapa P, Tarrell R, Tollefson MK, Jeffrey Karnes R, Frank I, Khanna A, Shah P, Sharma V, Boorjian SA. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series. Urology. 2023 Nov; 181:162-166 Epub 2023 Sept 07
    View PubMed
  12. Britton CJ, Sharma V, Fadel AE, Bearrick E, Findlay BL, Frank I, Tollefson MK, Karnes RJ, Viers BR. Vesicourethral Anastomotic Stenosis Following Radical Prostatectomy: Risk Factors, Natural History, and Treatment Outcomes. J Urol. 2023 Aug; 210 (2):312-322 Epub 2023 Apr 20
    View PubMed
  13. Zganjar A, Toussi A, Ziegelmann M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial. BJU Int. 2023 Aug; 132 (2):217-226 Epub 2023 May 09
    View PubMed
  14. Linder BJ, Anderson SS, Boorjian SA, Tollefson MK, Habermann EB. Effect of Surgical Care Team Consistency During Urologic Procedures on Surgical Efficiency and Perioperative Outcomes. Urology. 2023 May; 175:84-89 Epub 2023 Feb 17
    View PubMed
  15. Myers A, Frank I, Shah PH, Tarrell RF, Baird B, Dora C, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA, Lyon TD. Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy. J Urol. 2023 Mar; 209 (3):525-531 Epub 2022 Nov 29
    View PubMed
  16. Avulova S, Benidir T, Cheville JC, Packiam VT, Shah P, Frank I, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Kulkarni G, Boorjian SA. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy. Arch Pathol Lab Med. 2023 Feb 1; 147 (2):202-207
    View PubMed
  17. Joyce DD, Soligo M, Morlacco A, Latuche LJR, Schulte PJ, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy. Eur Urol Open Sci. 2023 Jan; 47:87-93 Epub 2022 Dec 15
    View PubMed
  18. Andrews JR, Ahmed ME, Sharma V, Britton C, Stish B, Phillips R, Kendi AT, Joshi VB, Sood A, Tollefson MK, Boorjian SA, Karnes RJ, Kwon ED. Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. J Urol. 2022 Dec; 208(6):1240-1249. Epub 2022 Nov 09.
    View PubMed
  19. Norasi H, Tetteh E, Law KE, Ponnala S, Hallbeck MS, Tollefson M. Intraoperative workload during robotic radical prostatectomy: Comparison between multi-port da Vinci Xi and single port da Vinci SP robots. Appl Ergon. 2022 Oct; 104:103826. Epub 2022 Jun 17.
    View PubMed
  20. Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. NCCN Guidelines(R) Insights: Bladder Cancer, Version 2.2022. J Natl Compr Canc Netw. 2022 Aug; 20 (8):866-878
    View PubMed
  21. Tsivian M, Bole R, Packiam VT, Boorjian SA, Thapa P, Frank I, Tollefson MK. The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic Outcomes. Urology. 2022 Jul; 165:128-133 Epub 2022 Jan 15
    View PubMed
  22. Anderson AL, Tollefson MK, Frank I, Peffley ND, Schroeder DR, Gali B. Intraoperative Ventilatory Pressures During Robotic Assisted vs Open Radical Cystectomy. Urology. 2022 Jun; 164:157-162 Epub 2021 Dec 10
    View PubMed
  23. Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SA. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558. Epub 2021 Oct 25.
    View PubMed
  24. Miest T, Khanna A, Sharma V, Hensley PJ, Campbell R, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Potretzke A, Matin SF, Murthy PB, Haber GP, Lee B, Boorjian SA. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy. J Urol. 2022 Feb; 207(2):284-292. Epub 2021 Sep 22.
    View PubMed
  25. Manka MG, Viers BR, Bole R, Nichols PE, Boorjian SA, Tollefson MK, Linder BJ. Assessing the Impact of Hospital Dismissal Summary Readability on Patient Outcomes Following Prostatectomy. Urology. 2021 Nov; 157:201-205 Epub 2021 July 22
    View PubMed
  26. Parikh NN, Spinner RJ, Tollefson MK, Linder BJ. An Unusual Complication of Retropubic Midurethral Sling Placement: Obturator Neuralgia. Urology. 2021 Oct; 156:e96-e98 Epub 2021 July 03
    View PubMed
  27. Khanna A, Zganjar A, Lyon T, Shah P, Tollefson MK, Karnes RJ, Tarrell R, Thapa P, Thompson RH, Frank I, Boorjian SA. A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy. J Urol. 2021 Oct; 206 (4):970-977 Epub 2021 May 25
    View PubMed
  28. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206 (3):558-567 Epub 2021 Apr 28
    View PubMed
  29. Miest TS, Sharma V, Karnes RJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK. Incidence and predictors of occult preoperative deep vein thrombosis at radical cystectomy for urothelial carcinoma. Can Urol Assoc J. 2021 Sep; 15 (9):E471-E475
    View PubMed
  30. Gao RW, Tollefson MK, Thompson RH, Potretzke AM, Quevedo FJ, Choo R, Davis BJ, Pisansky TM, Harmsen WS, Stish BJ. Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy. Pract Radiat Oncol. 2021 Sep-Oct; 11 (5):e468-e476 Epub 2021 Feb 23
    View PubMed
  31. Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021 Aug; 206 (2):416-426 Epub 2021 June 01
    View PubMed
  32. Packiam VT, Labbate CV, Boorjian SA, Tarrell R, Cheville JC, Avulova S, Sharma V, Tsivian M, Adamic B, Mahmoud M, Werntz RP, Smith ND, Karnes RJ, Tollefson MK, Steinberg GD, Frank I. The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis. Urol Oncol. 2021 Jul; 39 (7):436.e1-436.e8 Epub 2021 Jan 21
    View PubMed
  33. Miest TS, Sharma V, Boeri L, Tollefson MK, Thompson RH, Boorjian SA, Frank I, Karnes RJ. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications? Urology. 2021 Jul; 153:215-220 Epub 2020 Aug 05
    View PubMed
  34. Ahmed ME, Andrews JR, Joshi VB, Mynderse LA, Tollefson MK, Karnes RJ, Kwon ED. Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):689-692 Epub 2021 May 26
    View PubMed
  35. Lyon TD, Frank I, Tollefson MK, Tarrell RF, Shah PH, Thompson RH, Karnes RJ, Boorjian SA. Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy. Urol Oncol. 2021 Jun; 39 (6):370.e1-370.e8 Epub 2020 Dec 08
    View PubMed
  36. Lyon TD, Henry MR, Shah PH, Boorjian SA, Tollefson MK, Frank I. Development of a technique for evaluating the presence of malignant cells in prostatic fluid during robotic prostatectomy. Urol Oncol. 2021 Mar; 39 (3):192.e1-192.e6 Epub 2020 Aug 29
    View PubMed
  37. Bearrick EN, Packiam V, Bhindi B, Lohse CM, Cheville JC, Mason RJ, Tollefson M, Harrington S, Dong H, Parker AS, Boorjian SA, Thompson RH, Leibovich BC. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. Urol Oncol. 2021 Feb; 39 (2):135.e1-135.e8 Epub 2020 Dec 09
    View PubMed
  38. Packiam VT, Tsivian M, Avulova S, Sharma V, Tarrell R, Cheville JC, Frank I, Thompson RH, Tollefson MK, Gettman MT, Karnes RJ, Thapa P, Boorjian SA. Long-term outcomes of incidental prostate cancer at radical cystectomy. Urol Oncol. 2020 Nov; 38 (11):848.e17-848.e22 Epub 2020 July 02
    View PubMed
  39. Joseph JP, Glasgow AE, Carlson RE, Frank I, Tollefson MK, Boorjian SA, Thompson RH, Karnes RJ, Habermann EB, Gettman MT. Screening Postoperative Hemoglobin after Robot-Assisted Radical Prostatectomy-Frequently Used, but Is It Necessary? Urol Pract. 2020 Nov; 7(6):554-558. Epub 2019 Dec 02.
    View PubMed
  40. Becerra MF, Venkatramani V, Reis IM, Soodana-Prakash N, Punnen S, Gonzalgo ML, Raolji S, Castle EP, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Parekh DJ. Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy. J Urol. 2020 Sep; 204 (3):450-459 Epub 2020 Apr 09
    View PubMed
  41. Andrews JR, Sobol I, Frank I, Gettman MT, Thompson RH, Karnes RJ, Boorjian SA, Tollefson MK. Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection. Urology. 2020 Sep; 143:181-185 Epub 2020 June 17
    View PubMed
  42. Sharma V, Wymer KM, Borah BJ, Saigal CS, Litwin MS, Packiam VT, Thompson RH, Tollefson MK, Karnes RJ, Boorjian SA. Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer. J Urol. 2020 Sep; 204 (3):442-449 Epub 2020 Mar 19
    View PubMed
  43. Agarwal DK, Sharma V, Toussi A, Viers BR, Tollefson MK, Gettman MT, Frank I. Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies. Eur Urol. 2020 Mar; 77 (3):373-379 Epub 2019 Apr 19
    View PubMed
  44. Venkatramani V, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Soodana-Prakash N, Becerra MF, Swain S, Kendrick K, Smith JA Jr, Thompson IM, Parekh DJ. Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup. J Urol. 2020 Mar; 203 (3):522-529 Epub 2019 Sept 24
    View PubMed
  45. Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Eggener S, Smaldone M, Minhaj Siddiqui M, Tollefson M, Chapin BF. Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. Prostate Cancer Prostatic Dis. 2020 Mar; 23 (1):172-178 Epub 2019 Sept 09
    View PubMed
  46. Boswell TC, Hebert KJ, Tollefson MK, Viers BR. Robotic urethral reconstruction: redefining the paradigm of posterior urethroplasty. Transl Androl Urol. 2020 Feb; 9 (1):121-131
    View PubMed
  47. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. AUTHOR REPLY. Urology 2020 Feb; 136:111
    View PubMed
  48. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy. Urology. 2020 Feb; 136:105-111 Epub 2019 Nov 09
    View PubMed
  49. Joseph JP, Potretzke TA, Packiam V, Sharma V, Toussi A, Miest TS, Juvet T, Boorjian SA, Thompson RH, Welle CL, Atwell TD, Leibovich BC, Tollefson MK, Potretzke AM. Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma. Urology. 2020 Jan; 135:95-100 Epub 2019 Oct 23
    View PubMed
  50. Yang DY, Frank I, Avant RA, Miller AR, Thapa P, Boorjian SA, Tollefson MK. Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy. Urol Oncol. 2019 Dec; 37 (12):886-892 Epub 2019 Aug 17
    View PubMed
  51. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Tarrel R, Quevedo FJ, Cheville JC, Karnes RJ. Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience. World J Urol. 2019 Nov; 37 (11):2409-2418 Epub 2019 Feb 25
    View PubMed
  52. Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease. World J Urol. 2019 Aug; 37 (8):1605-1613 Epub 2018 Nov 03
    View PubMed
  53. Hebert KJ, Joseph J, Gettman M, Tollefson M, Frank I, Viers BR. Technical Considerations of Single Port Ureteroneocystostomy Utilizing da Vinci SP Platform. Urology. 2019 Jul; 129:236 Epub 2019 Mar 30
    View PubMed
  54. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes. Eur Urol Oncol. 2019 Jul; 2 (4):390-396 Epub 2018 Sept 28
    View PubMed
  55. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ. Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience. BJU Int. 2019 Jun; 123 (6):1011-1019 Epub 2019 Jan 08
    View PubMed
  56. Lyon TD, Frank I, Takahashi N, Boorjian SA, Moynagh MR, Shah PH, Tarrell RF, Cheville JC, Viers BR, Tollefson MK. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2019 Jun; 17 (3):216-222.e5 Epub 2019 Mar 25
    View PubMed
  57. Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy. Int Braz J Urol. 2019 May-Jun; 45 (3):468-477
    View PubMed
  58. Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK. Comprehensive characterization of perioperative reoperation following radical cystectomy. Urol Oncol. 2019 Apr; 37 (4):292.e11-292.e17 Epub 2019 Jan 22
    View PubMed
  59. Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. The Association of Aspirin Use with Survival Following Radical Cystectomy. J Urol. 2018 Nov; 200 (5):1014-1021 Epub 2018 May 30
    View PubMed
  60. Arora K, Hanson KT, Habermann EB, Tollefson MK, Psutka SP. Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and Obesity. Bladder Cancer. 2018 Oct 29; 4 (4):377-388
    View PubMed
  61. Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer. Scand J Urol. 2018 Oct - Dec; 52 (5-6):340-348 Epub 2019 Jan 02
    View PubMed
  62. Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA. Temporal trends in venous thromboembolism after radical cystectomy. Urol Oncol. 2018 Aug; 36 (8):361.e15-361.e21 Epub 2018 June 07
    View PubMed
  63. Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK. Examining the association between adiposity and biochemical recurrence after radical prostatectomy. Can Urol Assoc J. 2018 Jul; 12 (7):E331-E337 Epub 2018 Mar 19
    View PubMed
  64. Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA Jr, Thompson IM. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018 Jun 23; 391 (10139):2525-2536
    View PubMed
  65. Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK. The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy. Clin Genitourin Cancer. 2018 Jun; 16 (3):e629-e636 Epub 2017 Dec 06
    View PubMed
  66. Bailey GC, Frank I, Tollefson MK, Gettman MT, Knoedler JJ. Perioperative outcomes of robot-assisted laparoscopic partial cystectomy. J Robot Surg. 2018 Jun; 12 (2):223-228 Epub 2017 June 10
    View PubMed
  67. Li R, Ravizzini GC, Gorin MA, Maurer T, Eiber M, Cooperberg MR, Alemozzaffar M, Tollefson MK, Delacroix SE, Chapin BF. The use of PET/CT in prostate cancer. Prostate Cancer Prostatic Dis. 2018 Apr; 21 (1):4-21 Epub 2017 Dec 11
    View PubMed
  68. Agarwal DK, Viers BR, Rivera ME, Nienow DA, Frank I, Tollefson MK, Gettman MT. Physical activity monitors can be successfully implemented to assess perioperative activity in urologic surgery. Mhealth. 2018; 4:43 Epub 2018 Sept 26
    View PubMed
  69. Evans JD, Hansen CC, Tollefson MK, Hallemeier CL. Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report. Adv Radiat Oncol. 2018 Jan-Mar; 3 (1):57-61 Epub 2017 Aug 30
    View PubMed
  70. Mason RJ, Frank I, Bhindi B, Tollefson MK, Thompson RH, Karnes RJ, Tarrell R, Thapa P, Boorjian SA. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes. World J Urol. 2017 Dec; 35 (12):1879-1884 Epub 2017 Sept 14
    View PubMed
  71. Bhindi B, Karnes RJ, Rangel LJ, Mason RJ, Gettman MT, Frank I, Tollefson MK, Lin DW, Thompson RH, Boorjian SA. Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification. J Urol. 2017 Dec; 198 (6):1286-1294 Epub 2017 June 29
    View PubMed
  72. Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Tollefson MK, Frank I. Oncologic surveillance following radical cystectomy: an individualized risk-based approach. World J Urol. 2017 Dec; 35 (12):1863-1869 Epub 2017 July 06
    View PubMed
  73. Bhindi B, Carlson RE, Mason RJ, Schulte PJ, Gettman MT, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Leibovich BC, Karnes RJ. Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin. Urology. 2017 Nov; 109:145-152 Epub 2017 Aug 18
    View PubMed
  74. Bhindi B, Frank I, Mason RJ, Tarrell RF, Thapa P, Cheville JC, Costello BA, Pagliaro LC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017 Nov; 72 (5):660-664 Epub 2017 May 22
    View PubMed
  75. Bhindi B, Lohse CM, Mason RJ, Westerman ME, Cheville JC, Tollefson MK, Boorjian SA, Thompson RH, Leibovich BC. Are We Using the Best Tumor Size Cut-points for Renal Cell Carcinoma Staging? Urology. 2017 Nov; 109:121-126 Epub 2017 Apr 12
    View PubMed
  76. Nehra AK, Gettman MT, Rivera ME, Agarwal DK, O'Neil DA, Jenkins SM, Tollefson MK, Viers BR. A Survey of Perceptions and Acceptance of Wearable Technology for Health Monitoring in a Urological Patient Population. Urol Pract. 2017 Nov; 4 (6):508-514 Epub 2016 Oct 24
    View PubMed
  77. Yang DY, Thompson RH, Zaid HB, Lohse CM, Rule AD, Boorjian SA, Leibovich BC, Cheville JC, Tollefson MK. Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy. J Urol. 2017 Oct; 198 (4):795-802 Epub 2017 Apr 08
    View PubMed
  78. Parker WP, Smelser W, Lee EK, Habermann EB, Thapa P, Zaid HB, Frank I, Griebling TL, Tollefson MK, Thompson RH, Holzbeierlein JM, Karnes RJ, Boorjian SA. Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients. Clin Genitourin Cancer. 2017 Aug 1 Epub 2017 Aug 01
    View PubMed
  79. Parker WP, Habermann EB, Day CN, Zaid HB, Frank I, Thompson RH, Tollefson MK, Boorjian SA, Pagliaro LC, Karnes RJ. Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy. Clin Genitourin Cancer. 2017 Jul 22 Epub 2017 July 22
    View PubMed
  80. Bhindi B, Rangel LJ, Mason RJ, Gettman MT, Frank I, Kwon ED, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration. J Urol. 2017 Jul; 198 (1):86-91 Epub 2017 Jan 24
    View PubMed
  81. Gershman B, Meier SK, Jeffery MM, Moreira DM, Tollefson MK, Kim SP, Karnes RJ, Shah ND. Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of Care. J Urol. 2017 Jul; 198 (1):92-99 Epub 2017 Jan 30
    View PubMed
  82. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Tollefson MK, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2017 Apr; 71 (4):560-567 Epub 2016 Sept 24
    View PubMed
  83. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71 (3):340-348 Epub 2016 Sept 03
    View PubMed
  84. Tollefson MK. Editorial Comment. J Urol 2017 Jan; 197 (1):82 Epub 2016 Oct 04
    View PubMed
  85. Parker WP, Tollefson MK, Heins CN, Hanson KT, Hanson KT, Habermann EB, Zaid HB, Frank I, Thompson RH, Boorjian SA. Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program. Urol Oncol. 2016 Dec; 34 (12):532.e13-532.e19 Epub 2016 Aug 05
    View PubMed
  86. Viers BR, Thompson RH, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Tollefson MK. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors. World J Urol. 2016 Dec; 34 (12):1693-1699 Epub 2016 Apr 06
    View PubMed
  87. Westerman ME, Parker WP, Viers BR, Rivera ME, Karnes RJ, Frank I, Tarrell R, Thapa P, Thompson RH, Tollefson MK, Boorjian SA. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes. Urol Oncol. 2016 Nov; 34(11):485.e1-485.e6. Epub 2016 Jul 14.
    View PubMed
  88. Zaid HB, Yang DY, Tollefson MK, Frank I, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Safety and Efficacy of Extended Duration of Thromboembolic Prophylaxis Following Radical Cystectomy: An Initial Institutional Experience. Urol Pract. 2016 Nov; 3 (6):462-467 Epub 2016 Aug 18
    View PubMed
  89. Moreira DM, Gershman B, Rangel LJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Gettman MT, Karnes RJ. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU Int. 2016 Sep; 118: (3)379-83.
    View PubMed
  90. Parker WP, Toussi A, Tollefson MK, Frank I, Thompson RH, Zaid HB, Thapa P, Boorjian SA. Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy. Urology. 2016 Aug; 94:96-101. Epub 2016 Apr 25.
    View PubMed
  91. Zaid HB, Yang DY, Tollefson MK, Frank I, Winters JL, Thapa P, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy. Urology. 2016 Jun; 92:57-62. Epub 2016 Mar 08.
    View PubMed
  92. Toussi A, Stewart-Merrill SB, Boorjian SA, Psutka SP, Thompson RH, Frank I, Tollefson MK, Gettman MT, Carlson RE, Rangel LJ, Karnes RJ. Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression? J Urol. 2016 Jun; 195(6):1754-9. Epub 2015 Dec 23.
    View PubMed
  93. Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ. Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup. J Urol. 2016 Jun; 195 (6):1773-8 Epub 2015 Dec 23
    View PubMed
  94. Tollefson MK. Editorial Comment. Urology. 2016 Mar; 89:67-8.
    View PubMed
  95. Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. J Urol. 2016 Feb; 195 (2):270-6 Epub 2015 Aug 18
    View PubMed
  96. McEachen JC, Leng S, Atwell TD, Tollefson MK, Friese JL, Wang Z, Murad MH, Schmit GD. Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation. Cardiovasc Intervent Radiol. 2016 Feb; 39: (2)233-8.
    View PubMed
  97. Kaushik D, Boorjian SA, Thompson RH, Eisenberg MS, Carlson RE, Bergstralh EJ, Frank I, Gettman MT, Tollefson MK, Karnes RJ. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. Int Braz J Urol. 2016 Nov-Dec; 42(6):1091-1098.
    View PubMed
  98. Zaid HB, Yang DY, Tollefson MK, Frank I, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Safety and efficacy of extended duration of thromboembolic prophylaxis following radical cystectomy: an initial institutional experience Urology Practice. 2016; 3(6):462-7. Epub 1900 Jan 01.
  99. Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Urol Oncol. 2016 Jan; 34 (1):4.e1-9 Epub 2015 Aug 29
    View PubMed
  100. Jaeger CD, Cockerill PA, Gettman MT, Tollefson MK. Presentation, Endoscopic Management, and Significance of Hemostatic Clip Migration into the Lower Urinary Tract Following Radical Prostatectomy. J Laparoendosc Adv Surg Tech A. 2015 Oct; 25 (10):800-3 Epub 2015 Sept 30
    View PubMed
  101. Viers BR, Lightner DJ, Rivera ME, Tollefson MK, Boorjian SA, Karnes RJ, Thompson RH, O'Neil DA, Hamilton RL, Gardner MR, Bundrick M, Jenkins SM, Pruthi S, Frank I, Gettman MT. Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial. Eur Urol. 2015 Oct; 68 (4):729-35 Epub 2015 Apr 18
    View PubMed
  102. Gustafson MP, Lin Y, Bleeker JS, Warad D, Tollefson MK, Crispen PL, Bulur PA, Harrington SM, Laborde RR, Gastineau DA, Leibovich BC, Cheville JC, Kwon ED, Dietz AB. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2015 Sep 15; 21 (18):4224-33 Epub 2015 May 21
    View PubMed
  103. Viers BR, Houston Thompson R, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK, Boorjian SA. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy. Urol Oncol. 2015 Sep; 33 (9):388.e11-8 Epub 2015 Feb 17
    View PubMed
  104. Eggener SE, Badani K, Barocas DA, Barrisford GW, Cheng JS, Chin AI, Corcoran A, Epstein JI, George AK, Gupta GN, Hayn MH, Kauffman EC, Lane B, Liss MA, Mirza M, Morgan TM, Moses K, Nepple KG, Preston MA, Rais-Bahrami S, Resnick MJ, Siddiqui MM, Silberstein J, Singer EA, Sonn GA, Sprenkle P, Stratton KL, Taylor J, Tomaszewski J, Tollefson M, Vickers A, White WM, Lowrance WT. Gleason 6 prostate cancer: translating biology into population health. J Urol. 2015 Sep; 194(3):626-34.
    View PubMed
  105. Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson MK, Frank I. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. Urol Oncol. 2015 Aug; 33(8):339.e1-8. Epub 2015 May 29.
    View PubMed
  106. Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Frank I, Carrasco A, Stewart SB, Tarrell R, Thapa P, Tollefson MK. Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting. J Urol. 2015 May; 193 (5):1507-13 Epub 2014 Nov 22
    View PubMed
  107. Rivera M, Granberg CF, Tollefson MK. Robotic-assisted laparoscopic surgery of urachal anomalies: a single-center experience. J Laparoendosc Adv Surg Tech A. 2015 Apr; 25 (4):291-4
    View PubMed
  108. Clifton MM, Psutka SP, Boorjian SA, Cheville JC, Thapa P, Thompson RH, Tollefson MK, Karnes RJ, Frank I. Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy. World J Urol. 2015 Mar; 33 (3):373-9 Epub 2014 May 15
    View PubMed
  109. Psutka SP, Boorjian SA, Lohse CM, Stewart SB, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. Urol Oncol. 2015 Feb; 33 (2):67.e15-23 Epub 2014 Aug 19
    View PubMed
  110. Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SP, Bergstralh EJ, Rangel L, Karnes RJ. Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):332-7. Epub 2014 Aug 26.
    View PubMed
  111. Viers BR, Sukov WR, Gettman MT, Rangel LJ, Bergstralh EJ, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy. Eur Urol. 2014 Dec; 66: (6)1116-24.
    View PubMed
  112. Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. J Urol. 2014 Dec; 192 (6):1620-7 Epub 2014 June 12
    View PubMed
  113. Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014 Dec; 66 (6):1157-64 Epub 2014 Feb 26
    View PubMed
  114. Knoedler JJ, Boorjian SA, Tollefson MK, Cheville JC, Thapa P, Tarrell RF, Frank I. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy. BJU Int. 2014 Dec; 114(6):832-6.
    View PubMed
  115. Yelfimov DA, Frank I, Boorjian SA, Thapa P, Cheville JC, Tollefson MK. Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer. World J Urol. 2014 Dec; 32 (6):1463-8 Epub 2014 Jan 14
    View PubMed
  116. Viers BR, Tollefson MK, Patterson DE, Gettman MT, Krambeck AE. Simultaneous vs staged treatment of urolithiasis in patients undergoing radical prostatectomy. World J Clin Cases. 2014 Nov 16; 2 (11):698-704
    View PubMed
  117. Viers BR, Houston Thompson R, Boorjian SA, Lohse CM, Leibovich BC, Tollefson MK. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. Urol Oncol. 2014 Nov; 32 (8):1277-84 Epub 2014 July 10
    View PubMed
  118. Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, Stewart SB, Thapa P, Tarrell RF, Cheville JC, Tollefson MK. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014 Sep 15; 120 (18):2910-8 Epub 2014 May 19
    View PubMed
  119. Yelfimov DA, Lightner DJ, Tollefson MK. Urologic manifestations of Erdheim-Chester disease. Urology. 2014 Jul; 84(1):218-21. Epub 2014 Apr 27.
    View PubMed
  120. Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, Rangel LJ, King BF, Mynderse LA. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol. 2014 Jun; 21 (3):7283-9
    View PubMed
  121. Schneider SA, Sukov WR, Frank I, Boorjian SA, Costello BA, Tarrell RF, Thapa P, Houston Thompson R, Tollefson MK, Jeffrey Karnes R, Cheville JC. Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. Mod Pathol. 2014 May; 27 (5):758-64 Epub 2013 Nov 01
    View PubMed
  122. Tollefson MK, Karnes RJ, Kwon ED, Lohse CM, Rangel LJ, Mynderse LA, Cheville JC, Sebo TJ. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Mayo Clin Proc. 2014 Mar; 89 (3):308-18 Epub 2014 Jan 31
    View PubMed
  123. Tollefson MK, Karnes RJ, Rangel L, Carlson R, Boorjian SA. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy. J Urol. 2014 Mar; 191(3):646-51. Epub 2013 Oct 17.
    View PubMed
  124. Eisenberg MS, Thompson RH, Frank I, Kim SP, Cotter KJ, Tollefson MK, Kaushik D, Thapa P, Tarrell R, Boorjian SA. Long-term renal function outcomes after radical cystectomy. J Urol. 2014 Mar; 191 (3):619-25 Epub 2013 Sept 12
    View PubMed
  125. Smith ND, Castle EP, Gonzalgo ML, Svatek RS, Weizer AZ, Montgomery JS, Pruthi RS, Woods ME, Tollefson MK, Konety BR, Shabsigh A, Krupski T, Barocas DA, Dash A, Quek ML, Kibel AS, Parekh DJ. The RAZOR (randomized open vs robotic cystectomy) trial: Study design and trial update. BJU Int. 2014; 115(2):198-205.
  126. Wang JK, Boorjian SA, Frank I, Tarrell RF, Thapa P, Jacob EK, Tauscher CD, Tollefson MK. Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy. Urology. 2014 Jan; 83(1):140-5. Epub 2013 Oct 16.
    View PubMed
  127. Tollefson MK, Boorjian SA, Gettman MT, Rangel LJ, Bergstralh EJ, Karnes RJ. Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy. Urol Oncol. 2013 Nov; 31 (8):1483-8 Epub 2012 May 10
    View PubMed
  128. Wang JK, Tollefson MK, Kim SP, Boorjian SA, Leibovich BC, Lohse CM, Cheville JC, Thompson RH. Iatrogenic splenectomy during nephrectomy for renal tumors. Int J Urol. 2013 Sep; 20 (9):896-902 Epub 2013 Feb 04
    View PubMed
  129. Kim SP, Shah ND, Weight CJ, Thompson RH, Wang JK, Karnes RJ, Han LC, Ziegenfuss JY, Frank I, Tollefson MK, Boorjian SA. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. BJU Int. 2013 Aug; 112 (4):478-84 Epub 2013 Mar 01
    View PubMed
  130. Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. J Urol. 2013 Jul; 190 (1):55-60 Epub 2013 Jan 09
    View PubMed
  131. Kim SP, Shah ND, Karnes RJ, Weight CJ, Shippee ND, Han LC, Boorjian SA, Smaldone MC, Frank I, Gettman MT, Tollefson MK, Thompson RH. Hospitalization costs for radical prostatectomy attributable to robotic surgery. Eur Urol. 2013 Jul; 64(1):11-6. Epub 2012 Aug 20.
    View PubMed
  132. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol. 2013 May; 63 (5):839-45 Epub 2013 Jan 11
    View PubMed
  133. Tollefson MK, Karnes RJ, Rangel LJ, Bergstralh EJ, Boorjian SA. The impact of clinical stage on prostate cancer survival following radical prostatectomy. J Urol. 2013 May; 189 (5):1707-12 Epub 2012 Nov 15
    View PubMed
  134. Gustafson MP, Lin Y, LaPlant B, Liwski CJ, Maas ML, League SC, Bauer PR, Abraham RS, Tollefson MK, Kwon ED, Gastineau DA, Dietz AB. Immune monitoring using the predictive power of immune profiles. J Immunother Cancer. 2013; 1:7. Epub 2013 Jun 27.
    View PubMed
  135. Clifton MM, Tollefson MK. Anatomic basis of radical cystectomy and orthotopic urinary diversion in female patients. Clin Anat. 2013 Jan; 26(1):105-9. Epub 2012 Nov 30.
    View PubMed
  136. Tollefson MK, Boorjian SA, Farmer SA, Frank I. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease. World J Urol. 2012 Dec; 30 (6):795-9 Epub 2012 Mar 25
    View PubMed
  137. Boorjian SA, Tollefson MK, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy. J Urol. 2012 Nov; 188(5):1761-6. Epub 2012 Sep 19.
    View PubMed
  138. Kim SP, Boorjian SA, Shah ND, Karnes RJ, Weight CJ, Moriarty JP, Tollefson MK, Shippee ND, Frank I. Contemporary trends of in-hospital complications and mortality for radical cystectomy. BJU Int. 2012 Oct; 110 (8):1163-8 Epub 2012 Mar 22
    View PubMed
  139. Kim SP, Shah ND, Karnes RJ, Weight CJ, Frank I, Moriarty JP, Han LC, Borah B, Tollefson MK, Boorjian SA. The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. J Urol. 2012 Jun; 187 (6):2011-7 Epub 2012 Apr 11
    View PubMed
  140. Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012 Mar; 79(3):615-9.
    View PubMed
  141. Boorjian SA, Tollefson MK, Rangel LJ, Bergstralh EJ, Karnes RJ. Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):56-62. Epub 2011 Aug 02.
    View PubMed
  142. Boorjian SA, Tollefson MK, Cheville JC, Costello BA, Thapa P, Frank I. Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. J Urol. 2011 Nov; 186 (5):1796-802 Epub 2011 Sept 25
    View PubMed
  143. Tollefson MK, Frank I, Gettman MT. Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections. Urology. 2011 Oct; 78(4):827-31. Epub 2011 Jul 29.
    View PubMed
  144. Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol. 2011 Jun; 59 (6):893-9 Epub 2011 Feb 22
    View PubMed
  145. Tollefson MK, Gettman MT, Blute ML, Bergstralh EJ, Rangel LJ, Karnes RJ. Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy. Urology. 2011 May; 77(5):1161-5. Epub 2010 Dec 03.
    View PubMed
  146. Tollefson MK, Gettman MT, Karnes RJ, Frank I. Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy. J Urol. 2011 May; 185 (5):1686-90 Epub 2011 Mar 21
    View PubMed
  147. Shimko MS, Tollefson MK, Umbreit EC, Farmer SA, Blute ML, Frank I. Long-term complications of conduit urinary diversion. J Urol. 2011 Feb; 185 (2):562-7 Epub 2010 Dec 18
    View PubMed
  148. Tollefson MK, Boorjian SA, Lohse CM, Blute ML, Leibovich BC. The impact of family history on pathological and clinical outcomes in non-syndromic clear cell renal cell carcinoma. BJU Int. 2010 Dec; 106 (11):1638-42
    View PubMed
  149. Tollefson MK, Blute ML, Rangel LJ, Karnes RJ, Frank I. Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy. J Urol. 2010 Sep; 184(3):925-9.
    View PubMed
  150. Tollefson M, Magera J, Sebo T, Cohen J, Drauch A, Maier J, Frank I. Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology? BJU Int. 2010 Aug; 106(4):484-8. Epub 2010 Mar 01.
    View PubMed
  151. Tollefson MK, Krambeck AE, Leibovich BC, Blute ML, Chow GK. Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. Urology. 2010 Jun; 75(6):1373-7. Epub 2009 Oct 07.
    View PubMed
  152. Tollefson MK, Blute ML, Rangel LJ, Bergstralh EJ, Boorjian SA, Karnes RJ. The effect of Gleason score on the predictive value of prostate-specific antigen doubling time. BJU Int. 2010 May; 105 (10):1381-5 Epub 2009 Oct 26
    View PubMed
  153. Tollefson MK, Elliott DS, Zincke H, Frank I. Long-term outcome of ureterosigmoidostomy: an analysis of patients with >10 years of follow-up. BJU Int. 2010 Mar; 105(6):860-3. Epub 2009 Aug 13.
    View PubMed
  154. Umbreit EC, Dozois EJ, Crispen PL, Tollefson MK, Karnes RJ, Blute ML. Radical prostatectomy for prostate cancer after ileal pouch-anal anastomosis offers oncologic control and sustains quality of life. J Am Coll Surg. 2010 Feb; 210 (2):232-9 Epub 2009 Dec 03
    View PubMed
  155. Tollefson MK, Blute ML, Farmer SA, Frank I. Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. J Urol. 2010 Jan; 183 (1):81-6
    View PubMed
  156. Routh JC, Tollefson MK, Ashley RA, Husmann DA. Iatrogenic ureteral injury: can adult repair techniques be used on children? J Pediatr Urol. 2009 Feb; 5(1):53-5. Epub 2008 Oct 21.
    View PubMed
  157. Granberg CF, Boorjian SA, Crispen PL, Tollefson MK, Farmer SA, Frank I, Blute ML. Functional and oncological outcomes after orthotopic neobladder reconstruction in women. BJU Int. 2008 Dec; 102 (11):1551-5 Epub 2008 Oct 08
    View PubMed
  158. Tollefson MK, Ashley RA, Routh JC, Husmann DA. Traumatic obliterative urethral strictures in pediatric patients: failure of the cut to light technique at long-term followup. J Urol. 2007 Oct; 178(4 Pt 2):1656-8; discussion 1658. Epub 2007 Aug 17.
    View PubMed
  159. Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer. 2007 Aug 15; 110 (4):783-90
    View PubMed
  160. Tollefson MK, Slezak JM, Leibovich BC, Zincke H, Blute ML. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc. 2007 Apr; 82(4):422-7.
    View PubMed
  161. Tollefson M, Boorjian S, Leibovich B. Complications of the incision and patient positioning. Complications of Urologic Surgery. 2007:225-36.
  162. Tollefson MK, Takahashi N, Leibovich BC. Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma. Curr Urol Rep. 2007 Jan; 8 (1):38-43
    View PubMed
  163. Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol. 2006 Feb; 175 (2):547-51
    View PubMed
  164. Tollefson MK, Kawashima A, Blute ML. In situ partial nephrectomy and tumor thrombectomy for renal cell carcinoma with level II vena cava extension in a solitary kidney. Urology. 2005 Oct; 66(4):882.
    View PubMed
  165. Park JJ, Wolff BG, Tollefson MK, Walsh EE, Larson DR. Meckel diverticulum: the Mayo Clinic experience with 1476 patients (1950-2002). Ann Surg. 2005 Mar; 241 (3):529-33
    View PubMed
  166. Tollefson MK, Libsch KD, Sarr MG, Chari ST, DiMagno EP, Urrutia R, Smyrk TC. Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas. 2003 Apr; 26 (3):e55-8
    View PubMed